Role of common cytokine receptor γ chain (γ(c))- and Jak3-dependent signaling in the proliferation and survival of murine mast cells

Blood

Volumn 96, Issue 6, 2000, Pages 2172-2180

  Suzuki, K ^a   Nakajima, H ^a   Watanabe, N ^a   Kagami, S I ^a   Suto, A ^a   Saito, Y ^a   Saito, T ^a   Iwamoto, I ^a  

^a Chiba University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; INTERLEUKIN RECEPTOR; JANUS KINASE; STAT6 PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; IMMEDIATE TYPE HYPERSENSITIVITY; MOUSE; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0034665901     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.6.2172     Document Type: Article

References (63)

1. Mast cell and basophil development
2. Mast cells
3. + mast cells and their progenitors to IL-3 and stem cell factor
4. Identification of a committed precursor for the mast cell lineage
5. The interleukin-2 receptor γ chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
6. The molecular basis of X-linked severe combined immunodeficiency: Defective cytokine receptor signaling
7. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans
8. Lymphoid development in mice with a targeted deletion of the interleukin-2 receptor α chain
9. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
10. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ chain
11. Jaks and STATs: Biological implications
12. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
13. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
14. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
15. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice
16. + severe combined immunodeficiency
17. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain
18. + cell development
19. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
20. IL-4 induces allergic-like inflammatory disease and alter T cell development in transgenic mice
21. Effects of interleukin-3 and interleukin-4 on the development of 'connective tissue-type' mast cells: Interleukin-3 supports their survival and interleukin-4 triggers and supports their proliferation synergistically with interleukin-3
22. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis
23. Effects of T-helper 2-type cytokines, IL-3, IL-4, IL-5, and IL-6 on the survival of cultured human mast cells
24. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9)
25. Interleukin-9 and its receptor: Involvement in mast cell differentiation and T cell oncogenesis
26. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells
27. Lymphocyte responses and cytokines
28. The IL-4 receptor: Signaling mechanisms and biologic functions
29. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors
30. Function of the interleukin-2 (IL-2) receptor γ-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15
31. X-SCID B cell responses to interleukin-4 and interleukin-13 are mediated by a receptor complex that includes the interleukin-4 receptor α chain (p140) but not the γ(c) chain
32. Mouse macrophage development in the absence of the common γ chain: Defining receptor complexes responsible for IL-4 and IL-13 signaling
33. The role of IL-13 and its receptor in allergy and inflammatory responses
34. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens
35. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
36. Jak3 is essential for γ(c)-dependent signaling: Comparative analysis of γ(c), Jak3, and γ(c) and Jak3 double-deficient mice
37. Biological properties of homogeneous interleukin 3 I. Demonstration of WEHI-3 growth-factor activity, mast cell growth factor activity, P cell-stimulating factor activity and histamine-producing factor activity
38. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5, using modified cDNA expression vectors
39. Basophil and mast cell lineages in vitro and in vivo
40. The common cytokine receptor γ chain plays an essential role in regulating lymphoid homeostasis
41. Mast cells induce autoantibody-mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fcγ receptors
42. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4
43. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells
44. IL-4 and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common γ chain
45. IL-4 enhances proliferation and mediator release in mature human mast cells
46. A comparative study of peritoneal mast cells from mutant IL-4 deficient and normal mice: Evidence that IL-4 is not essential for mast cell development but enhances secretion via control of IgE binding and passive sensitization
47. The IL-2 receptor γ(c) chain does not function as a subunit shared by the IL-4 and IL-13 receptors
48. Interleukin-13: Central mediator of allergic asthma
49. Requirement for IL-13 independently of IL-4 in experimental asthma
50. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor α subunit
51. Homodimerization of the human interleukin 4 receptor α chain induces Cε germline transcripts in B cells in the absence of the interleukin 2 receptor γ chain
52. The IL-4 receptor α-chain cytoplasmic domain is sufficient for activation of JAK-1 and-STAT6 and the induction of IL-4-specific gene expression
53. Essential role of Stat6 in IL-4 signaling
54. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
55. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
56. IL-4 inhibits mouse mast cell FcεRI expression through a STAT6-dependent mechanism
57. IL-13, IL-4Rα, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis
58. IL-4 preferentially activates a novel STAT6 isoform in mast cells
59. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6
60. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6
61. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation
62. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
63. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice